Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2016

25.08.2016

Repeat procedures after second-generation cryoballoon ablation as an index procedure for persistent atrial fibrillation: one-year follow-up

verfasst von: Hugo Enrique Coutiño, Carlo de Asmundis, Giacomo Mugnai, Darragh Moran, Valentina De Regibus, Erwin Ströker, Ken Takarada, Diego Ruggiero, Rajin Choudhury, Stefan Beckers, Carla Van Gompel, Jan Poelaert, Saverio Iacopino, Pasquale Filannino, Pedro Brugada, Gian-Battista Chierchia

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Data indicate that the second-generation cryoballoon (Arctic Front Advance, Medtronic, Minnesota, USA) could be effective for persistent atrial fibrillation. However, electrophysiological findings and the midterm clinical outcome of repeat procedures following second-generation cryoballoon ablation are lacking.

Methods

Consecutive patients with drug-resistant persistent atrial fibrillation who underwent a repeat ablation due to arrhythmia recurrence following an index procedure with second-generation cryoballoon were retrospectively included in our analysis. A total of 24 patients were included. Twenty underwent repeat procedures because of atrial fibrillation or left atrial arrhythmias and four because of typical atrial flutter. Mean time to recurrence of atrial tachyarrhythmias was 6.6 ± 3 months. Mean redo procedural time was 122 ± 23 min.

Results

At a mean follow-up of 11.8 ± 6.5 months, 15 patients (75 %) did not experience recurrence of atrial arrhythmias. Of the five patients (25 %) who had recurrence of atrial tachyarrhythmia, four presented with persistent atrial fibrillation and one with a mitral isthmus-dependent flutter. Of note is that the four patients with typical flutter were free from atrial tachycardia recurrence after the redo procedure. Two patients (9 %) underwent a third procedure. Mean time to recurrence of atrial arrhythmias from the repeat procedure was 9 ± 1 months.

Conclusions

Our findings show that repeat ablation procedures following a second-generation cryoballoon ablation for persistent atrial fibrillation result in 75 % of freedom from any atrial tachycardia at 12 months follow-up. Of the recurrences, 63 % were due to new onset of atrial fibrillation and 37 % to organized tachycardias.
Literatur
1.
Zurück zum Zitat Mugnai G, de Asmundis C, Ciconte G, Irfan G, Saitoh Y, Velagic V, et al. Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: a large single-center study of 500 consecutive patients. Heart Rhythm. 2015;12:1476–82.CrossRefPubMed Mugnai G, de Asmundis C, Ciconte G, Irfan G, Saitoh Y, Velagic V, et al. Incidence and characteristics of complications in the setting of second-generation cryoballoon ablation: a large single-center study of 500 consecutive patients. Heart Rhythm. 2015;12:1476–82.CrossRefPubMed
2.
Zurück zum Zitat Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G, et al. Long-term outcomes after cryoballoon pulmonary vein isolation. Results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61:1707–12.CrossRefPubMed Vogt J, Heintze J, Gutleben KJ, Muntean B, Horstkotte D, Nölker G, et al. Long-term outcomes after cryoballoon pulmonary vein isolation. Results from a prospective study in 605 patients. J Am Coll Cardiol. 2013;61:1707–12.CrossRefPubMed
3.
Zurück zum Zitat Mugnai G, de Asmundis C, Hünük B, Ströker E, Velagic V, Moran D, et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: predictive role of atrial arrhythmias occurring in the blanking period on the incidence of late recurrences. Heart Rhythm. 2016; 13:845–51. Mugnai G, de Asmundis C, Hünük B, Ströker E, Velagic V, Moran D, et al. Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: predictive role of atrial arrhythmias occurring in the blanking period on the incidence of late recurrences. Heart Rhythm. 2016; 13:845–51.
4.
Zurück zum Zitat Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G, et al. Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation. Heart Rhythm. 2015;12:673–80.CrossRefPubMed Ciconte G, de Asmundis C, Sieira J, Conte G, Di Giovanni G, Mugnai G, et al. Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation. Heart Rhythm. 2015;12:673–80.CrossRefPubMed
5.
Zurück zum Zitat January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland Jr JC, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64:e1–76.CrossRefPubMed January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland Jr JC, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64:e1–76.CrossRefPubMed
6.
Zurück zum Zitat Calkins H, Kuck K, Cappato R, Brugada J, Camm J, Chen S, et al. 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606.CrossRefPubMed Calkins H, Kuck K, Cappato R, Brugada J, Camm J, Chen S, et al. 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606.CrossRefPubMed
7.
Zurück zum Zitat Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J, et al. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: one-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12:60–6.CrossRefPubMed Ciconte G, Ottaviano L, de Asmundis C, Baltogiannis G, Conte G, Sieira J, et al. Pulmonary vein isolation as index procedure for persistent atrial fibrillation: one-year clinical outcome after ablation using the second-generation cryoballoon. Heart Rhythm. 2015;12:60–6.CrossRefPubMed
8.
Zurück zum Zitat Kenigsberg DN, Martin N, Lim HW, Kowalski M, Ellenbogen KA. Quantification of the cryoablation zone demarcated by pre and postprocedural electroanatomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. Heart Rhythm. 2015;12:283–90.CrossRefPubMed Kenigsberg DN, Martin N, Lim HW, Kowalski M, Ellenbogen KA. Quantification of the cryoablation zone demarcated by pre and postprocedural electroanatomic mapping in patients with atrial fibrillation using the 28-mm second-generation cryoballoon. Heart Rhythm. 2015;12:283–90.CrossRefPubMed
9.
Zurück zum Zitat Malcolme-Lawes LC, Lim PB, Wright I, Kojodjojo P, Koa-Wing M, Jamil-Copley S, et al. Characterization of the left atrial neural network and its impact on autonomic modification procedures. Circ Arrhythm Electrophysiol. 2013;6:632–40.CrossRefPubMed Malcolme-Lawes LC, Lim PB, Wright I, Kojodjojo P, Koa-Wing M, Jamil-Copley S, et al. Characterization of the left atrial neural network and its impact on autonomic modification procedures. Circ Arrhythm Electrophysiol. 2013;6:632–40.CrossRefPubMed
10.
Zurück zum Zitat Verma A, Sanders P, Macle L, Deisenhofer I, Morillo CA, Chen J, et al. Substrate and trigger ablation for reduction of atrial fibrillation trial—part II (STAR AF II): design and rationale. Am Heart J. 2012;164:1–6.e6.CrossRefPubMed Verma A, Sanders P, Macle L, Deisenhofer I, Morillo CA, Chen J, et al. Substrate and trigger ablation for reduction of atrial fibrillation trial—part II (STAR AF II): design and rationale. Am Heart J. 2012;164:1–6.e6.CrossRefPubMed
11.
Zurück zum Zitat Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43:2044–53.CrossRefPubMed Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43:2044–53.CrossRefPubMed
12.
Zurück zum Zitat Rostock T, Rotter M, Sanders P, Takahashi Y, Jaïs P, Hocini M, et al. High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm. 2006;3:27–34.CrossRefPubMed Rostock T, Rotter M, Sanders P, Takahashi Y, Jaïs P, Hocini M, et al. High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm. 2006;3:27–34.CrossRefPubMed
13.
Zurück zum Zitat Jais P, O’Neill M, Takahashi Y, Jonsson A, Hocini M, Sacher F, et al. Stepwise catheter ablation of chronic atrial fibrillation: importance of discrete anatomic sites for termination. J Interv Card Electrophysiol. 2006;16(3):153–67.CrossRefPubMed Jais P, O’Neill M, Takahashi Y, Jonsson A, Hocini M, Sacher F, et al. Stepwise catheter ablation of chronic atrial fibrillation: importance of discrete anatomic sites for termination. J Interv Card Electrophysiol. 2006;16(3):153–67.CrossRefPubMed
14.
Zurück zum Zitat Pokushalov E, Romanov A, Artyomenko S, Turov A, Shugayev P, Shirokova N, et al. Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace. 2010;12:342–6.CrossRefPubMed Pokushalov E, Romanov A, Artyomenko S, Turov A, Shugayev P, Shirokova N, et al. Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace. 2010;12:342–6.CrossRefPubMed
15.
Zurück zum Zitat Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller JM. Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol. 2013;62:138–47.CrossRefPubMedPubMedCentral Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller JM. Direct or coincidental elimination of stable rotors or focal sources may explain successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol. 2013;62:138–47.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Narayan SM, Krummen DE, Enyeart MW, Rappel W. Computational mapping approach identifies stable and long-lived electrical rotors and focal sources in human atrial fibrillation. PLoS One. 2012;7:e46034.CrossRefPubMedPubMedCentral Narayan SM, Krummen DE, Enyeart MW, Rappel W. Computational mapping approach identifies stable and long-lived electrical rotors and focal sources in human atrial fibrillation. PLoS One. 2012;7:e46034.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Mikhaylov EN, Lebedev DS, Pokushalov EA, Davtyan KV, Ivanitskii EA, Nechepurenko AA, et al. Outcomes of cryoballoon ablation in high- and low-volume atrial fibrillation ablation centres: a Russian pilot survey. Biomed Res Int. 2015;2015:591603.CrossRefPubMedPubMedCentral Mikhaylov EN, Lebedev DS, Pokushalov EA, Davtyan KV, Ivanitskii EA, Nechepurenko AA, et al. Outcomes of cryoballoon ablation in high- and low-volume atrial fibrillation ablation centres: a Russian pilot survey. Biomed Res Int. 2015;2015:591603.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Tscholl V, Lsharaf KA, Lin T, Bellmann B, Biewener S, Nagel P, et al. Two years outcome in patients with persistent atrial fibrillation after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Heart Rhythm. 2016. doi:10.1016/j.hrthm.2016.05.022. Tscholl V, Lsharaf KA, Lin T, Bellmann B, Biewener S, Nagel P, et al. Two years outcome in patients with persistent atrial fibrillation after pulmonary vein isolation using the second-generation 28-mm cryoballoon. Heart Rhythm. 2016. doi:10.​1016/​j.​hrthm.​2016.​05.​022.
19.
Zurück zum Zitat Straube F, Hartl S, Dorwarth U, Wankerl M, Bunz B, Ebersberger U, et al. Cryoballoon ablation for persistent atrial fibrillation—large single-center experience. J Cardiol. 2016. doi:10.1016/j.jjcc.2016.02.007. Straube F, Hartl S, Dorwarth U, Wankerl M, Bunz B, Ebersberger U, et al. Cryoballoon ablation for persistent atrial fibrillation—large single-center experience. J Cardiol. 2016. doi:10.​1016/​j.​jjcc.​2016.​02.​007.
20.
Zurück zum Zitat Koektuerk B, Yorgun H, Hengeoez O, Turan CH, Dahmen A, Yang A, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8:1073–9.CrossRefPubMed Koektuerk B, Yorgun H, Hengeoez O, Turan CH, Dahmen A, Yang A, et al. Cryoballoon ablation for pulmonary vein isolation in patients with persistent atrial fibrillation: one-year outcome using second generation cryoballoon. Circ Arrhythm Electrophysiol. 2015;8:1073–9.CrossRefPubMed
21.
Zurück zum Zitat Metzner A, Heeger CH, Wohlmuth P, Reißman B, Rillig A, Tilz R, et al. Two-year outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon: lessons from the bonus freeze protocol. Clin Res Cardiol. 2016;105:72–8.CrossRefPubMed Metzner A, Heeger CH, Wohlmuth P, Reißman B, Rillig A, Tilz R, et al. Two-year outcome after pulmonary vein isolation using the second-generation 28-mm cryoballoon: lessons from the bonus freeze protocol. Clin Res Cardiol. 2016;105:72–8.CrossRefPubMed
22.
Zurück zum Zitat Franceschi F, Koutbi L, Mancini J, Attarian S, Prevôt S, Deharo JC. Novel electromyographic monitoring technique for prevention of right phrenic nerve palsy during cryoballoon ablation. Circ Arrhythm Electrophysiol. 2013;6:1109–14.CrossRefPubMed Franceschi F, Koutbi L, Mancini J, Attarian S, Prevôt S, Deharo JC. Novel electromyographic monitoring technique for prevention of right phrenic nerve palsy during cryoballoon ablation. Circ Arrhythm Electrophysiol. 2013;6:1109–14.CrossRefPubMed
Metadaten
Titel
Repeat procedures after second-generation cryoballoon ablation as an index procedure for persistent atrial fibrillation: one-year follow-up
verfasst von
Hugo Enrique Coutiño
Carlo de Asmundis
Giacomo Mugnai
Darragh Moran
Valentina De Regibus
Erwin Ströker
Ken Takarada
Diego Ruggiero
Rajin Choudhury
Stefan Beckers
Carla Van Gompel
Jan Poelaert
Saverio Iacopino
Pasquale Filannino
Pedro Brugada
Gian-Battista Chierchia
Publikationsdatum
25.08.2016
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2016
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-016-0179-5

Weitere Artikel der Ausgabe 3/2016

Journal of Interventional Cardiac Electrophysiology 3/2016 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.